AI filing briefs · archive

8-K filings in December 2025, explained

619 material Form 8-K filings that 507 companies we cover made with the SEC in December 2025, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).

Clear

6 of 619 briefs match

newest first · times in ET
CRWDCrowdStrike Holdings, Inc. Dec 29, 5:15 PM ET

CrowdStrike grants CEO George Kurtz performance award of 300,000 target PSUs

Neutral leadership Written later 5.027.01

On December 22, 2025, CrowdStrike's independent directors approved a performance-based equity award for President and CEO George Kurtz, with a target of 300,000 performance stock units (PSUs). The payout depends on relative total stockholder return against S&P 500 companies over December 22, 2025 to December 22, 2028, and can range from zero to up to 600,000 shares. For shareholders, the award ties Kurtz's pay to stock performance relative to the index, while the company says it is intended to retain him.

  • Target award of 300,000 PSUs; no shares are earned if relative TSR falls below the 25th percentile of S&P 500 companies, and up to 600,000 shares are possible at or above the 90th percentile.
  • Three-year performance period runs from December 22, 2025 to December 22, 2028.
  • The filing cites a share price of $483.14 and market capitalization of $121.3 billion as of December 22, 2025.
  • The award is tied to a change-in-control provision and to Kurtz's continued service; the full terms are in Exhibit 10.1.
Read the filing on SEC.gov ↗
ECHOEchoStar CORP Dec 29, 5:05 PM ET

EchoStar names Hamid Akhavan CEO; new letter agreement sets pay terms

Neutral leadership Written later 5.02

EchoStar entered a new letter agreement with Hamid Akhavan, tied to his appointment as Chief Executive Officer, effective December 26, 2025. The agreement replaces his October 2, 2023 letter agreement and keeps his base salary and bonus opportunity unchanged. For shareholders, the filing details compensation terms for the new CEO but reports no financial results.

  • Hamid Akhavan was appointed Chief Executive Officer; the Letter Agreement is effective December 26, 2025.
  • Base salary and bonus opportunity continue unchanged under the new agreement.
  • Final tranche of his December 31, 2023 option award would accelerate vesting upon a Qualifying Termination.
  • The Letter Agreement expires December 31, 2026; future equity awards are at the discretion of the Chairman and Executive Compensation Committee.
Read the filing on SEC.gov ↗
CVICVR ENERGY INC Dec 29, 4:20 PM ET

CVR Energy names Mark Pytosh CEO effective January 1, 2026, succeeding David Lamp

Neutral leadership Written later 5.02

CVR Energy's board appointed Mark A. Pytosh as President and Chief Executive Officer effective January 1, 2026, succeeding David L. Lamp, who leaves the role effective December 31, 2025. The board also added Pytosh to its board of directors, expanding it from nine to ten seats, and he will receive no director pay while employed by the company.

  • Mark A. Pytosh, age 60, appointed President and CEO effective January 1, 2026, replacing David L. Lamp, who ceases as CEO effective December 31, 2025.
  • Pytosh has been Executive Vice President – Corporate Services since January 2018 and will keep his roles as director and CEO of the general partner of CVR Partners, LP (NYSE: UAN).
  • Board size increased from nine to ten; Pytosh fills the new seat effective January 1, 2026, without board compensation while employed by the company.
  • His CEO compensation follows his Employment Agreement dated July 28, 2025, previously disclosed in a July 31, 2025 10-Q filing.
Read the filing on SEC.gov ↗
CCITIGROUP INC Dec 29, 4:17 PM ET

Citigroup to sell Russian unit AO Citibank, expects $1.2 billion pre-tax loss in Q4

Mixed m&a Written later 8.01

Citigroup's board approved on December 29, 2025 a plan to sell AO Citibank, which holds the bank's remaining Russian operations, and will report that business as held for sale from the fourth quarter of 2025. The sale is expected to sign and close in the first half of 2026, and Citi expects a pre-tax loss on sale of approximately $1.2 billion ($1.1 billion after-tax) in the fourth quarter, mostly from currency translation losses. Citi says the cumulative translation impact would be capital neutral to its Common Equity Tier 1 Capital, but the loss remains subject to change, including from foreign exchange movements.

  • Board approved the plan on December 29, 2025 to sell AO Citibank, which conducts Citi's remaining operations in Russia.
  • Expected pre-tax loss on sale of approximately $1.2 billion ($1.1 billion after-tax) in Q4 2025, recorded as a reduction of Other Revenue.
  • The loss includes approximately $1.6 billion of currency translation adjustment losses, partly offset by about $0.2 billion from derecognition of a fully reserved investment and about $0.2 billion of expected sale proceeds.
  • Sale expected to sign and close in the first half of 2026; amounts are as of September 30, 2025.
Read the filing on SEC.gov ↗
PTCTPTC THERAPEUTICS, INC. Dec 29, 4:05 PM ET

PTC Therapeutics sells Evrysdi royalty to Royalty Pharma for $240 million upfront

Mixed financing Written later 1.01

PTC Therapeutics sold its retained interest in its Evrysdi royalty stream to Royalty Pharma Investments 2019 ICAV on December 29, 2025, for $240.0 million in upfront cash. The company also may receive three additional $20.0 million payments, each tied to royalty payments exceeding set thresholds in 2027, 2028 and 2029, and it no longer owns any part of the royalty.

  • Upfront cash consideration of $240.0 million paid to PTC Therapeutics on December 29, 2025
  • Three potential $20.0 million payments, conditioned on Assigned Royalty Payments above $347.0 million (2027), $363.0 million (2028) and $379.0 million (2029)
  • Retained interest sold was 9.5111% of the Royalty before the 2020 Assigned Royalty Cap is met and 16.6666% after; PTC now owns 0% of the Royalty
Read the filing on SEC.gov ↗
ALVAUTOLIV INC Dec 29, 10:13 AM ET

Autoliv CFO Fredrik Westin's resignation date moved to March 31, 2026

Neutral leadership Written later 5.02

Autoliv and Chief Financial Officer Fredrik Westin agreed on December 29, 2025, to delay his resignation from January 1, 2026 to March 31, 2026. He stays in the role through that date while the company continues recruiting a successor, and the filing says he will receive his normal compensation through the duration of his employment.

  • Westin's resignation as CFO and EVP, Finance moves from January 1, 2026 to March 31, 2026.
  • The change was agreed between Westin and the company on December 29, 2025.
  • The company says the recruitment of a successor as CFO and EVP, Finance continues.
  • Under his employment agreement, Westin is entitled to his normal compensation through the duration of his employment.
Read the filing on SEC.gov ↗

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.

Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.